The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development and validation of longitudinal c-reactive protein as dynamic response predictor for PD-L1 blockade in advanced NSCLC: Findings from four atezolizumab clinical trials.
 
Jian-Guo Zhou
No Relationships to Disclose
 
Xiaofei Chen
Employment - Sanofi
 
Ada Hang-Heng Wong
No Relationships to Disclose
 
Haitao Wang
No Relationships to Disclose
 
Fangya Tan
Employment - BMS Brazil
 
Si-Si He
No Relationships to Disclose
 
Gang Shen
No Relationships to Disclose
 
YunJia Wang
No Relationships to Disclose
 
Ruihong Wang
No Relationships to Disclose
 
Shamus R. Carr
No Relationships to Disclose
 
Benjamin Frey
No Relationships to Disclose
 
Rainer Fietkau
Honoraria - Abbvie; AstraZeneca; Merck Serono; Merck Serono; Merck Sharp & Dohme; MSD Oncology; Novocure; Sennewald GmbH
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Merck Serono; MSD Oncology; Novocure
Speakers' Bureau - AstraZeneca; Merck Serono; MSD; Novocure; Sennewald GmbH
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Debios (Inst); Merck (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novocure (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck; Merck Serono; MSD Oncology; Novocure; Sennewald GmbH
 
Markus Hecht
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Sanofi (Inst)
 
Hu Ma
No Relationships to Disclose
 
David S. Schrump
No Relationships to Disclose
 
Udo S Gaipl
No Relationships to Disclose